Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Liabilities and Shareholders Equity (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed Liabilities and Shareholders Equity for 3 consecutive years, with $43.3 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity changed N/A to $43.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $152.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $43.3 million for FY2025, N/A changed from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $43.3 million at Adagio Medical Holdings, up from $31.5 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $107.2 million in Q3 2024, with the low at $6.8 million in Q4 2023.
  • Average Liabilities and Shareholders Equity over 3 years is $44.3 million, with a median of $38.6 million recorded in 2025.
  • Peak annual rise in Liabilities and Shareholders Equity hit 70.57% in 2025, while the deepest fall reached 70.57% in 2025.
  • Over 3 years, Liabilities and Shareholders Equity stood at $6.8 million in 2023, then skyrocketed by 1470.64% to $107.2 million in 2024, then tumbled by 59.65% to $43.3 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $43.3 million, $31.5 million, and $35.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.